2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

Authors: Rodríguez-Carrio, J., Burska, A., Conaghan, P. G., Dik, W. A., Biesen, R., Eloranta, M.-L., Cavalli, G., Visser, M., Boumpas, D. T., Bertsias, G.

Source: Annals of the rheumatic diseases. 82(6):754-762

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632210267&indx=1&recIds=ETOCRN632210267

Annals of the Rheumatic Diseases collection on lupus nephritis (2019—2022): novel insights and advances in therapy

Authors: Kostopoulou, M., Fanouriakis, A., Bertsias, G., Boumpas, D. T.

Source: Annals of the rheumatic diseases. 82(6):729-733

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632210228&indx=1&recIds=ETOCRN632210228

Microglia activation in the presence of intact blood—brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus

Authors: Nikolopoulos, D., Manolakou, T., Polissidis, A., Filia, A., Bertsias, G., Koutmani, Y., Boumpas, D. T.

Source: Annals of the rheumatic diseases. 82(5):646-657

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631904139&indx=1&recIds=ETOCRN631904139

Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022

Authors: Winthrop, K. L., Isaacs, J. D., Mease, P. J., Boumpas, D. T., Baraliakos, X., Gottenberg, J.-E., Siebert, S., Mosca, M., Basu, N., Orange, D.

Source: Annals of the rheumatic diseases. 82(5):594-598

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631904062&indx=1&recIds=ETOCRN631904062

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

Authors: Drosos, G. C., Vedder, D., Houben, E., Boekel, L., Atzeni, F., Badreh, S., Boumpas, D. T., Brodin, N., Bruce, I. N., González-Gay, M. Á.

Source: Annals of the rheumatic diseases. 81(6):768-779

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN629399110&indx=1&recIds=ETOCRN629399110

Treatment of lupus: more options after a long wait

Authors: Kostopoulou, M., Fanouriakis, A., Bertsias, G., Boumpas, D. T.

Source: Annals of the rheumatic diseases. 81(6):753-756

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN629399080&indx=1&recIds=ETOCRN629399080

European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

Authors: Aringer, M., Brinks, R., Dörner, T., Daikh, D., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L.

Source: Annals of the rheumatic diseases. 80(6):775-781

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN626846372&indx=1&recIds=ETOCRN626846372

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus

Authors: Adamichou, C., Genitsaridi, I., Nikolopoulos, D., Nikoloudaki, M., Repa, A., Bortoluzzi, A., Fanouriakis, A., Sidiropoulos, P., Boumpas, D. T., Bertsias, G. K.

Source: Annals of the rheumatic diseases. 80(6):758-766

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN626846359&indx=1&recIds=ETOCRN626846359

Towards a realistic management of the problem of primary care in Greece

Authors: Boumpas, D. T., Mountokalakis, T.

Source: Archeia Hellēnikēs iatrikēs. 38(3):295-298

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN626743089&indx=1&recIds=ETOCRN626743089

Policies followed by four European countries in the management of Covid-19. Living well and dying well and the training of physicians

Authors: Boumpas, D. T., Panagiotakis, S. G., Tserkezoglou, A.

Source: Archeia Hellēnikēs iatrikēs. 38(3):410-414

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN626743237&indx=1&recIds=ETOCRN626743237

Update on the diagnosis and management of systemic lupus erythematosus

Authors: Fanouriakis, A., Tziolos, N., Bertsias, G., Boumpas, D. T.

Source: Annals of the rheumatic diseases. 80(1):14-25

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN625378710&indx=1&recIds=ETOCRN625378710

Atmospheric Pressure Plasma Functionalization of Sealed PDMS Microfluidics: Application to Capillary Pumping and Enhanced Cell Growth.

Authors: Zeniou, A.^1,2, Kefallinou, D.^1,2, Dimitrakellis, P.^1,2, Xenogiannopoulou, E.^1,2, Grigoriou, M.³, Dimoulas, A.^1,2, Boumpas, D. T.^3,4, Tserepi, A.^1,2, Gogolides, E.^1,2, e.gogolides@inn.demokritos.gr

Source: ChemPlusChem; Dec2024, Vol. 89 Issue 12, p1-11, 11p

Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

Authors: Johnson, S. R., Brinks, R., Costenbader, K. H., Daikh, D., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L.

Source: Annals of the rheumatic diseases. 79(10):1333-1339

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN624577757&indx=1&recIds=ETOCRN624577757

In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment

Authors: Adamichou, C., Nikolopoulos, D., Genitsaridi, I., Bortoluzzi, A., Fanouriakis, A., Papastefanakis, E., Kalogiannaki, E., Gergianaki, I., Sidiropoulos, P., Boumpas, D. T.

Source: Annals of the rheumatic diseases. 79(2):232-241

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN622865425&indx=1&recIds=ETOCRN622865425

Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection.

Authors: Nln, I, Shum, J, Ghodke-Puranik, Y, Tipon, R, Triese, D, Amin, S, Makol, A, Osborn, T, Chowdhary, V, Thanarajasingam, U, Muskardin, T L W, Oke, V, Gunnarsson, I, Zickert, A, Zervou, M I, Boumpas, D T, Svenungsson, E, Goulielmos, G N, Niewold, T B

Source: QJM: An International Journal of Medicine; Aug2024, Vol. 117 Issue 8, p581-588, 8p

Subject Terms: TYPE I interferons, VIRAL hepatitis, COVID-19, VIRUS diseases, DEATH rate

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

Authors: Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L.

Source: Annals of the rheumatic diseases. 78(9):1151-1159

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN621096290&indx=1&recIds=ETOCRN621096290

Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus

Authors: Tedeschi, S. K., Johnson, S. R., Boumpas, D. T., Daikh, D., Dörner, T., Diamond, B., Jacobsen, S., Jayne, D., Kamen, D. L., McCune, W. J.

Source: Annals of the rheumatic diseases. 78(5):634-640

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN619690033&indx=1&recIds=ETOCRN619690033

Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus

Authors: Papadaki, E., Fanouriakis, A., Kavroulakis, E., Karageorgou, D., Sidiropoulos, P., Bertsias, G., Simos, P., Boumpas, D. T.

Source: Annals of the rheumatic diseases. 77(3):441-449

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN614680994&indx=1&recIds=ETOCRN614680994

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database

Authors: Sfikakis, P. P., Bournia, V.-K., Sidiropoulos, P., Boumpas, D. T., Drosos, A. A., Kitas, G. D., Konstantonis, G., Liossis, S. N., Manoussakis, M. N., Sakkas, L.

Source: Clinical and experimental rheumatology. 35(4):579-585

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN612315253&indx=1&recIds=ETOCRN612315253

Toll like receptors and autoimmunity: A critical appraisal
International workshop on autoimmunity: physiological and pathophysiological aspects; Pathophysiology of autoimmune disease

Authors: Papadimitraki, E. D., Bertsias, G. K., Boumpas, D. T.

Source: JOURNAL OF AUTOIMMUNITY. 29(NO 4):310-318

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN066710498&indx=1&recIds=ETOCCN066710498